Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06187103 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Improved Onboard Patient Imaging

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Phase: Not applicable to Not specified
    • Primary completion date changed from estimate of Dec 2025 to Dec 5, 2025
    v6
  2. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: Oct 2025 to Dec 2025
    • Study completion date: Oct 2025 to Dec 2026
    • Site details revised
    v5
  3. Primary and study completion dates: Jun 2025 to Oct 2025
    • Eligibility criteria shortened, about 9 words
    • Secondary endpoints: 10 to 12
    v4
  4. Trial status: Not Yet Recruiting to Recruitingv3 Show 5 more changesShow less
    • Primary completion date: Apr 2025 to Jun 2025
    • Study completion date: May 2025 to Jun 2025
    • Start date changed from estimate of May 2024 to Jul 10, 2024
    • Secondary endpoints: 9 to 10
    • Site details revised
  5. Start date: Feb 2024 to May 2024
    • Primary completion date: Jan 2025 to Apr 2025
    • Study completion date: Jan 2025 to May 2025
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary objective of radiation therapy is to deliver a therapeutic dose of radiation precisely to the target while minimizing exposure to healthy surrounding tissues. Image-guided radiation therapy (IGRT) involves acquiring cone beam computed tomography (CBCT) scans just before or during treatment sessions. By comparing the CBCT images with the reference images from the treatment planning process, clinicians can make necessary adjustments to ensure precise targeting and account for any changes that may have occurred since the initial planning. Conventional CBCT technology is, however, limited by several factors including long acquisition times that result in motion artifacts in the image, smaller fields of view that limit the volume of anatomy that can be imaged, poor image quality that limits soft tissue visibility, and artifacts created by dense metal implants. This study will evaluate a novel CBCT imaging solution ("HyperSight") that has the potential to address the challenges of conventional CBCT.
Trial Details
NCT Number NCT06187103
Lead Sponsor Varian, a Siemens Healthineers Company
Conditions
(from sponsor)		 Head and Neck Cancer, Breast Cancer, Upper Gastrointestinal Cancer, Lung Cancer, Pelvic Cancer
Related terms Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Pelvic Neoplasms
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov